Recanalization and reperfusion therapies for acute ischemic stroke

Cerebrovascular Diseases

Volumn 27, Issue SUPPL. 1, 2009, Pages 162-167

  Molina, Carlos A ^a,b   Alvarez Sabín, José ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Acute ischemic stroke; Cerebral reperfusion; Outcome; Recanalization; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ARGATROBAN; DESMOTEPLASE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; MICROPLASMIN; NEUROPROTECTIVE AGENT; PLACEBO; PLASMIN; RETEPLASE; TENECTEPLASE; TINZAPARIN; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTIFICIAL EMBOLISM; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN MICROCIRCULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FIBRINOLYTIC THERAPY; HUMAN; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; REPERFUSION INJURY; STROKE PATIENT;

ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; HUMANS; NEUROPROTECTIVE AGENTS; PATIENT SELECTION; PLASMINOGEN ACTIVATORS; RECOVERY OF FUNCTION; REPERFUSION INJURY; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 64149124765     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000200455     Document Type: Conference Paper

References (18)

1. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S, ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.
2. Lyden P, TNK for Stroke Investigators: Pilot study of tenecteplase (TNK) in acute ischemic stroke:preliminary report. Stroke 2003; 34:246A.
3. Liberatore GT, Samson A, Bladin C, Schleuning WD, Medcalf RL: Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke 2003; 34:537-543.
4. Noble S, McTavish D: Reteplase. Areview of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 1996;52:589-605.
5. Lapchak PA, Araujo DM, Pakola S, Song D, Wei J, Zivin JA: Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 2002;33:2279-2284.
6. Adams HP Jr, Leclerc JR, Bluhmki E, Clarke W, Hansen MD, Hacke W: Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis 2004; 18: 124-129.
7. Seitz RJ, Meisel S, Moll M, Wittsack H-J, Junghans U, Siebler M: The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology 2004; 62:2110-2112.
8. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Ha milton S, Moseley M, Marks MP: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-517.
9. Davydov L, Cheng JW: Tenecteplase: a review. Clin Ther 2001;23:982-997.
10. Qureshi AI, Ali Z, Suri MF, Kim SH, Shatla AA, Ringer AJ, Lopes DK, Guterman LR, Hopkins LN: Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49: 41-48.
11. Marder VJ, Stewart D: Towards safer thrombolytic therapy. Semin Hematol 2002; 39: 206-216.
12. Gahn G, Kunz A, Putz V, Becker U, Goldhagen T, Hahn G, et al: Recanalization of middle cerebral artery occlusion after either t-PA or t-PA combined w it h abci xi mab (abstract). Stroke 2004;35:287.
13. De Georgia MA, Krieger DW, Abou-Chebl A, Devlin TG, Jauss M, Davis SM, Koroshetz WJ, Rordorf G, Warach S: Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology 2004;63:312-317.
14. Eggers J, Koch B, Meyer K, Konig I, Seidel G: Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol 2003;53:797-800.
15. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye LA, Hill MD, Wojner AW, CLOTBUST Investigators: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-2178.
16. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intraarterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. J Am Med Assoc 1999; 282:2003-2011.
17. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-911.
18. Starkman S, MERCI Investigators: Results of the combined MERCI I-II (Mechanical Embolus Removal in Cerebral Ischemia) Trials. Stroke 2004; 35:A240.